Johnson & Johnson (JNJ) Change in Accured Expenses (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Change in Accured Expenses data on file, last reported at -$629.0 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 90.34% year-over-year to -$629.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183.0 million (up 104.58% YoY) and the FY2025 annual result came in at -$5.7 billion, down 17363.64% from the prior year.
• Change in Accured Expenses fell to -$629.0 million in Q1 2026 per JNJ's latest filing, from $499.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $6.0 billion in Q3 2023, with the low at -$6.5 billion in Q1 2025.
• Average Change in Accured Expenses over 5 years is -$173.7 million, with a median of -$629.0 million recorded in 2026.
• Year-over-year, Change in Accured Expenses soared 263.32% in 2023 and sank 585.16% in 2025.
• Johnson & Johnson's Change in Accured Expenses stood at -$2.8 billion in 2022, then surged by 218.14% to $3.3 billion in 2023, then plunged by 89.21% to $359.0 million in 2024, then jumped by 39.0% to $499.0 million in 2025, then sank by 226.05% to -$629.0 million in 2026.
• Business Quant data shows JNJ's Change in Accured Expenses at -$629.0 million in Q1 2026, $499.0 million in Q4 2025, and -$5.3 billion in Q3 2025.